News Markets & Companies
IMCD increases EBITA to EUR 275 million – Six acquisitions strengthen market position
IMCD reports EBITA of EUR 275 million for the first half of 2025 and continues its growth trajectory with six acquisitions. Despite currency headwinds, the speciality chemicals distributor maintains solid margins and expands its portfolio.
The Dutch speciality chemicals distributor IMCD achieved EBITA of EUR 275 million in the first half of 2025 – an increase of 2 % compared to the same period last year (up 4 % at constant exchange rates). Revenue rose by 4 % to EUR 2.47 billion, while gross profit increased by 5 % to EUR 634 million. The gross margin edged up to 25.6 %.
Growth was driven by 2 % organic sales expansion and six completed acquisitions, which contributed 4 % to revenue. Negative currency effects impacted results by approximately 2 %. Despite a slight decrease in the EBITA margin to 11.1 % (previous year: 11.3 %), the company remains well positioned with a diversified portfolio across EMEA, the Americas and Asia-Pacific.
Regional performance and relevance for speciality chemicals
In EMEA, revenue grew by 4 % to EUR 1.07 billion. Gross profit rose slightly to EUR 293 million, while EBITA decreased by 4 % to EUR 124 million. Currency effects and weaker organic EBITA growth weighed on the results. Acquisitions in the region included Ferrer Alimentación (Iberia) and TECOM Ingredients (Spain), which expand the offering in food and beverage ingredients.
In the Americas, IMCD recorded a 6 % revenue increase to EUR 770 million and EBITA growth of 7 % to EUR 83 million. Contributions came from organic growth, acquisitions such as Apus Química (Chile) and Blumos Group (Chile, Peru, Argentina), and an expanded portfolio in performance chemicals and ingredients.
In Asia-Pacific, revenue grew slightly by 1 % to EUR 639 million, while gross profit increased more strongly by 7 % to EUR 150 million. EBITA rose by 5 % to EUR 86 million, supported by acquisitions such as YCAM (South Korea) and Daoqin (China) in personal care, pharmaceuticals and food ingredients.
Outlook: Focus on speciality markets and expansion
IMCD intends to further strengthen its market position in key segments of speciality chemicals – both organically and through targeted acquisitions. The company sees opportunities in geographic expansion and portfolio enhancement, particularly in high-margin sectors.
Despite macroeconomic uncertainties and currency fluctuations, IMCD considers itself well positioned to pursue its growth strategy thanks to its diversified business model and broad customer base.
